Sponsors

Expanded hepatitis B reagent range

Hepatitis B is a liver disease caused by the hepatitis B virus. Although a vaccine has been available since 1982, it is estimated that a third of the world’s population has been infected during their lifetime. This infectious disease is still common today in China.

Virostat has expanded its offering of hepatitis B reagents including its Monotope and Omnitope antibodies and recombinant antigens. Specificities include surface antigen (HBsAg), HB core, HB ‘e’, pre-s1, pre-s2 and HB-X. Applications for these reagents include enzyme-linked immunosorbent assay (ELISA), Western blot, immunohistochemistry (IHC) and rapid tests.
www.virostat-inc.com

Latest Issues

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026